Medical Marijuna, Inc. Investment AXIM(R) Biotech Receives Positive PK Data Results for CanChew Plus(R) CBD Gum

SAN DIEGO, CA –(Marketwired – January 09, 2017) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials with patients suffering from irritable bowel syndrome (IBS).

The single dose study on 10 mg of cannabidiol (CBD) and 30 mg of CBD determined the concentration of CBD in the blood after chewing one CanChew Plus® Gum for thirty minutes in healthy volunteers. The 30 mg dosage showed excellent results and this data will be used to determine the optimal concentration in the IBS patient trial.

“Yet

... read more at: http://finance.yahoo.com/news/medical-marijuna-inc-investment-axim-140000342.html

by